122 related articles for article (PubMed ID: 24378856)
1. Effect of the anti-diabetic drug metformin in hepatocellular carcinoma in vitro and in vivo.
Miyoshi H; Kato K; Iwama H; Maeda E; Sakamoto T; Fujita K; Toyota Y; Tani J; Nomura T; Mimura S; Kobayashi M; Morishita A; Kobara H; Mori H; Yoneyama H; Deguchi A; Himoto T; Kurokohchi K; Okano K; Suzuki Y; Murao K; Masaki T
Int J Oncol; 2013 Dec; ():. PubMed ID: 24378856
[TBL] [Abstract][Full Text] [Related]
2. Effect of the anti-diabetic drug metformin in hepatocellular carcinoma in vitro and in vivo.
Miyoshi H; Kato K; Iwama H; Maeda E; Sakamoto T; Fujita K; Toyota Y; Tani J; Nomura T; Mimura S; Kobayashi M; Morishita A; Kobara H; Mori H; Yoneyama H; Deguchi A; Himoto T; Kurokohchi K; Okano K; Suzuki Y; Murao K; Masaki T
Int J Oncol; 2014 Jul; 45(1):322-32. PubMed ID: 24806290
[TBL] [Abstract][Full Text] [Related]
3. The anti-diabetic drug metformin inhibits pancreatic cancer cell proliferation in vitro and in vivo: Study of the microRNAs associated with the antitumor effect of metformin.
Kato K; Iwama H; Yamashita T; Kobayashi K; Fujihara S; Fujimori T; Kamada H; Kobara H; Masaki T
Oncol Rep; 2016 Mar; 35(3):1582-92. PubMed ID: 26708419
[TBL] [Abstract][Full Text] [Related]
4. The antidiabetic drug metformin inhibits gastric cancer cell proliferation in vitro and in vivo.
Kato K; Gong J; Iwama H; Kitanaka A; Tani J; Miyoshi H; Nomura K; Mimura S; Kobayashi M; Aritomo Y; Kobara H; Mori H; Himoto T; Okano K; Suzuki Y; Murao K; Masaki T
Mol Cancer Ther; 2012 Mar; 11(3):549-60. PubMed ID: 22222629
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effect of metformin in esophageal cancer: in vitro study.
Kobayashi M; Kato K; Iwama H; Fujihara S; Nishiyama N; Mimura S; Toyota Y; Nomura T; Nomura K; Tani J; Miyoshi H; Kobara H; Mori H; Murao K; Masaki T
Int J Oncol; 2013 Feb; 42(2):517-24. PubMed ID: 23229592
[TBL] [Abstract][Full Text] [Related]
6. Anti-diabetic drug metformin inhibits cell proliferation and tumor growth in gallbladder cancer via G0/G1 cell cycle arrest.
Yamashita T; Kato K; Fujihara S; Iwama H; Morishita A; Yamana H; Kobayashi K; Kamada H; Chiyo T; Kobara H; Tsutsui K; Okano K; Suzuki Y; Masaki T
Anticancer Drugs; 2020 Mar; 31(3):231-240. PubMed ID: 31815765
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA profiles in cisplatin-induced apoptosis of hepatocellular carcinoma cells.
Miyata M; Morishita A; Sakamoto T; Katsura A; Kato K; Nishioka T; Toyota Y; Fujita K; Maeda E; Nomura T; Tani J; Miyoshi H; Yoneyama H; Kobara H; Fujiwara S; Nishiyama N; Iwama H; Himoto T; Hirashima M; Masaki T
Int J Oncol; 2015 Aug; 47(2):535-42. PubMed ID: 26060089
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effect of metformin on cholangiocarcinoma: In vitro and in vivo studies.
Fujimori T; Kato K; Fujihara S; Iwama H; Yamashita T; Kobayashi K; Kamada H; Morishita A; Kobara H; Mori H; Okano K; Suzuki Y; Masaki T
Oncol Rep; 2015 Dec; 34(6):2987-96. PubMed ID: 26398221
[TBL] [Abstract][Full Text] [Related]
9. Metformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivo.
Cai X; Hu X; Cai B; Wang Q; Li Y; Tan X; Hu H; Chen X; Huang J; Cheng J; Jing X
Oncol Rep; 2013 Nov; 30(5):2449-57. PubMed ID: 24008375
[TBL] [Abstract][Full Text] [Related]
10. Aspirin inhibits hepatocellular carcinoma cell proliferation in vitro and in vivo via inducing cell cycle arrest and apoptosis.
Shi T; Fujita K; Gong J; Nakahara M; Iwama H; Liu S; Yoneyama H; Morishita A; Nomura T; Tani J; Takuma K; Tadokoro T; Himoto T; Oura K; Tsutsui K; Kobara H; Masaki T
Oncol Rep; 2020 Aug; 44(2):457-468. PubMed ID: 32627038
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo anti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma.
Luo Q; Hu D; Hu S; Yan M; Sun Z; Chen F
BMC Cancer; 2012 Nov; 12():517. PubMed ID: 23151022
[TBL] [Abstract][Full Text] [Related]
12. Antidiabetic drug metformin inhibits esophageal adenocarcinoma cell proliferation in vitro and in vivo.
Fujihara S; Kato K; Morishita A; Iwama H; Nishioka T; Chiyo T; Nishiyama N; Miyoshi H; Kobayashi M; Kobara H; Mori H; Okano K; Suzuki Y; Masaki T
Int J Oncol; 2015 May; 46(5):2172-80. PubMed ID: 25709052
[TBL] [Abstract][Full Text] [Related]
13. Metformin Induced AMPK Activation, G0/G1 Phase Cell Cycle Arrest and the Inhibition of Growth of Esophageal Squamous Cell Carcinomas In Vitro and In Vivo.
Cai X; Hu X; Tan X; Cheng W; Wang Q; Chen X; Guan Y; Chen C; Jing X
PLoS One; 2015; 10(7):e0133349. PubMed ID: 26196392
[TBL] [Abstract][Full Text] [Related]
14. Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest.
Oura K; Tadokoro T; Fujihara S; Morishita A; Chiyo T; Samukawa E; Yamana Y; Fujita K; Sakamoto T; Nomura T; Yoneyama H; Kobara H; Mori H; Iwama H; Okano K; Suzuki Y; Masaki T
Oncol Rep; 2017 Nov; 38(5):2825-2835. PubMed ID: 29048654
[TBL] [Abstract][Full Text] [Related]
15. The antidiabetic drug metformin inhibits the proliferation of bladder cancer cells in vitro and in vivo.
Zhang T; Guo P; Zhang Y; Xiong H; Yu X; Xu S; Wang X; He D; Jin X
Int J Mol Sci; 2013 Dec; 14(12):24603-18. PubMed ID: 24351837
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo antitumoral action of metformin on hepatocellular carcinoma.
Qu Z; Zhang Y; Liao M; Chen Y; Zhao J; Pan Y
Hepatol Res; 2012 Sep; 42(9):922-33. PubMed ID: 22524458
[TBL] [Abstract][Full Text] [Related]
17. Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies.
Chen HP; Shieh JJ; Chang CC; Chen TT; Lin JT; Wu MS; Lin JH; Wu CY
Gut; 2013 Apr; 62(4):606-15. PubMed ID: 22773548
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of the antidiabetic drug metformin in small bowel adenocarcinoma.
Chiyo T; Kato K; Iwama H; Fujihara S; Fujita K; Tadokoro T; Ohura K; Samukawa E; Yamana Y; Kobayashi N; Matsunaga T; Nishiyama N; Ayaki M; Yachida T; Morishita A; Kobara H; Mori H; Masaki T
Int J Oncol; 2017 Jun; 50(6):2145-2153. PubMed ID: 28440424
[TBL] [Abstract][Full Text] [Related]
19. Vitamins K2, K3 and K5 exert in vivo antitumor effects on hepatocellular carcinoma by regulating the expression of G1 phase-related cell cycle molecules.
Kuriyama S; Hitomi M; Yoshiji H; Nonomura T; Tsujimoto T; Mitoro A; Akahane T; Ogawa M; Nakai S; Deguchi A; Masaki T; Uchida N
Int J Oncol; 2005 Aug; 27(2):505-11. PubMed ID: 16010434
[TBL] [Abstract][Full Text] [Related]
20. Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells.
Wu Y; Zheng Q; Li Y; Wang G; Gao S; Zhang X; Yan X; Zhang X; Xie J; Wang Y; Sun X; Meng X; Yin B; Wang B
J Exp Clin Cancer Res; 2019 Aug; 38(1):376. PubMed ID: 31455378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]